Physician profile
Coleen E Hart
NPI 1639541089
$1,460.85
in general payments reported to CMS, 2019-2025
20 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.81 · 2020: $75.73 · 2021: $12.59 · 2022: $314 · 2023: $340 · 2024: $385 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $984 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $984.16 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $457.25 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $290.85 | 2020-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $126.01 | 2022-2024 | Evenity |
| Phathom Pharmaceuticals, INC. | $106.29 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $86.73 | 2019-2023 | Steglatro, Belsomra, Segluromet |
| Xeris Pharmaceuticals, INC. | $65.66 | 2024-2025 | Gvoke Hypopen |
| Lilly USA, LLC | $60.87 | 2024-2025 | Mounjaro |
| Abbvie INC. | $39.55 | 2022-2023 | |
| Glaxosmithkline, LLC. | $30.68 | 2022-2024 | Bexsero, Rotarix, Pediarix |
| Jazz Pharmaceuticals INC. | $25.43 | 2023 | |
| Acera Surgical, INC. | $22.88 | 2023 | Restrata Wound Matrix |
| Bayer Healthcare Pharmaceuticals INC. | $19.59 | 2023 | |
| Axsome Therapeutics, INC. | $18.40 | 2023 | Sunosi |
| Almatica Pharma LLC | $17.73 | 2022 | |
| Pfizer INC. | $16.85 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16.24 | 2024 | Amplatzer Amulet |
| Biohaven Pharmaceutical Holding Company LTD. | $15.63 | 2022 | |
| Shield Therapeutics INC | $15.23 | 2023 | Accrufer |
| Kowa Pharmaceuticals America, INC. | $14.98 | 2025 | Zoryve |
| Exact Sciences Corporation | $14.00 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Coleen Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.